Miriam Provost - 13 Dec 2023 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role
VP, Global Regulatory Affairs
Signature
By: /s/ Stephen Gordon, Attorney-in-Fact
Issuer symbol
TMDX
Transactions as of
13 Dec 2023
Net transactions value
-$56,648
Form type
4
Filing time
15 Dec 2023, 17:31:17 UTC
Previous filing
05 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMDX Common Stock Options Exercise $6,698 +415 +1.8% $16.14 24,026 13 Dec 2023 Direct
transaction TMDX Common Stock Sale $15,471 -206 -0.86% $75.10 23,820 13 Dec 2023 Direct F1
transaction TMDX Common Stock Options Exercise $107,875 +1,632 +6.9% $66.10 25,452 13 Dec 2023 Direct
transaction TMDX Common Stock Sale $113,326 -1,509 -5.9% $75.10 23,943 13 Dec 2023 Direct F1
transaction TMDX Common Stock Options Exercise $138,341 +3,597 +15% $38.46 27,540 13 Dec 2023 Direct
transaction TMDX Common Stock Sale $180,766 -2,407 -8.7% $75.10 25,133 13 Dec 2023 Direct F1
transaction TMDX Common Stock Gift $0 -1,785 -7.1% $0.000000 23,348 15 Dec 2023 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMDX Stock Option (Right to Buy) Options Exercise $0 -415 -5% $0.000000 7,811 13 Dec 2023 Common Stock 415 $16.14 Direct F4
transaction TMDX Stock Option (Right to Buy) Options Exercise $0 -1,632 -19% $0.000000 7,073 13 Dec 2023 Common Stock 1,632 $66.10 Direct F5
transaction TMDX Stock Option (Right to Buy) Options Exercise $0 -3,597 -32% $0.000000 7,813 13 Dec 2023 Common Stock 3,597 $38.46 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exercise followed the sell-to-cover process, whereby a portion of the shares acquired through the exercise were sold in the open market, with the proceeds used to fund the aggregate exercise price of the options.
F2 On December 15, 2023, the reporting person donated 1,785 shares of directly owned common stock to a donor-advised fund, which will use the gifted shares for charitable purposes.
F3 Includes 5,685 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F4 The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020.
F5 The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 20, 2023.
F6 The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021.